Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border

NCT01152684 | Completed DMC

• 1 other identifier: R21AT004676-01A1
• Study Type: observational
• Target: 541
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of The investigators community-based participatory research study is to identify the nature and extent of complementary and alternative medicine (CAM) use among HIV-positive Latinos on the San Diego/Tijuana border. CAM use among US Latinos living with HIV is associated with delayed utilization of and poor adherence to antiretroviral therapies (ARVs) that may exacerbate health disparities in HIV care access and health outcomes. This study will lead to development of culturally-effective interventions to improve access and adherence to HIV care in Latinos who face health disparities. The investigators hypothesis is that greater use of CAM will be observed among HIV-positive Latinos who report a) crossing the U.S. border more frequently, and b) having migrated to Tijuana or San Diego (e.g. from southern Mexico). The investigators also hypothesize that compared to HIV-positive Latinos who report using herbal CAM, those who do not use herbal CAM are more likely to be receiving ARVs and report higher levels of adherence to ARVs; Compared to HIV-positive Latinos who do not attend religious services regularly, those who attend religious services regularly are more likely to be receiving ARV; Compared to HIV- positive Latinos who report experiencing HIV related stigma, those who do not report experiencing HIV-related stigma are significantly more likely to be receiving ARVs.

Conditions

HIV Positive

Keywords

CAM; HIV-Positive; Latinos; US-Mexico Border region; San Diego-Tijuana; Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region

Study Arms (1)

HIV-Positive Latinos living in San Diego or Tijuana

This is an exploratory study of Latinos living with HIV in the San Diego-Tijuana US-Mexico border region.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The population will be selected from 2 locations: 1. San Diego: San Ysidro Health Center(SYHC) will serve as the recruitment site on the US side of the border. Latinos comprise \>90% of SYHC's patient population. SYHC provides HIV primary medical care to over 400 HIV-positive individuals. SYHC's HIV-positive Latino patient population includes persons who may or may not be on ARVs and who participate in clinic services to varying degrees. Previous studies with HIV-positive patients at SYHC indicate cross-border mobility and bi-national care seeking behavior in this clinic population. 2.Tijuana: The Agencia Familiar Binacional (AFABI;Binational Health Agency) opened the first HIV medical and social services agency clinic in Tijuana. This clinic is in close proximity to the municipal health clinic, where a large number of HIV-positive cases are diagnosed, and is linked with other non-profit social services agencies for HIV-positive persons, many of whom face barriers to ARVs.

You may qualify if:

• Latino
• Speak English or Spanish or both
• Lived in San Diego or Tijuana for at least 1 month in the last year
• years or older
• HIV-positive or living with AIDS

You may not qualify if:

• Non-Latino
• Speak neither English nor Spanish
• Have not lived in San Diego or Tijuana for at least 1 month in the last year
• Under 18 years of age
• Not HIV-positive or living with AIDS

Sponsors & Collaborators

• University of California, San Diego: lead
• National Center for Complementary and Integrative Health (NCCIH): collaborator

Study Sites (1)

San Ysidro Health Center

San Ysidro, California, 92173, United States

Location

MeSH Terms

Conditions

HIV Seropositivity

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Study Officials

• Maria L Zúñiga, PhD

  University of California, San Diego

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 25, 2010
• First Posted: June 29, 2010
• Study Start: September 1, 2009
• Primary Completion: January 1, 2013
• Study Completion: January 1, 2013
• Last Updated: February 7, 2020

Record last verified: 2020-02

Locations

US (1)